Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 307.70
+3.95 (1.30%)
Nov 9, 2026, 11:40 AM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 139.44 billion as of November 6, 2026. It is the 7,970th most valuable company in the world and the 489th biggest in India. Its market cap has increased by 68.19% in one year.
Market Cap
139.44B
Enterprise Value
133.20B
Revenue
33.92B
Global Rank
Country Rank
#489 India
PE Ratio
24.91
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 139.44B, an increase of 3,718.60%. That is a compound annual growth rate of 20.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 139.44B | 70.67% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.46T |
| Divi's Laboratories | 2.74T |
| Laurus Labs | 1.26T |
| Lenskart Solutions | 1.26T |
| Molbio Diagnostics | 155.23B |
| Vijaya Diagnostic Centre | 151.49B |
| CORONA Remedies | 149.30B |
| Indegene | 146.95B |